IND Swift Laboratories Ltd Share Price

Overview

IND Swift Laboratories Ltd share price is currently ₹322.00, down by - ₹5.03 (1.54%) from its previous closing price of ₹327.03. The share price has gained 42.57% over the past month and gained 208.13% over the past year. The stock's 52-week low and high are ₹86.19 and ₹348.98, respectively. IND Swift Laboratories Ltd has a market capitalisation of ₹ 2,870.00 Cr. The share price was last updated on 24 Aug 2026, 03:29 PM IST.

IND Swift Laboratories Ltd

INDSWFTLAB

₹0.00

- ₹5.03

1.54%

Healthcare

₹0.00(%)1D

Updated: 24 Aug 2026, 03:29:47 pm IST

Market Data

Open Price

₹324.15

Prev. Close

₹327.03

₹321.65

Day Low

₹329.17

Day High

₹86.19

52 Week Low

₹348.98

52 Week High

HealthcarePharmaceuticals & Drugs

CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

47.85

Sector PE

42.03

PB Ratio

2.01

Sector PB

5.82

EPS

6.73

Dividend Yield

0.00

Today's Volume

478.903 K

5 Day Avg. Volume

1.643 M

PEG Ratio

-0.98

Market Cap.

₹ 2,870.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Ownership will be available shortly.

About IND Swift Laboratories Ltd 👋

Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Company's products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.